title: Obesity and hypertension: roles of hyperinsulinemia, sympathetic nervous system and intrarenal mechanisms.
abstract: Hypertension is a well-recognized complication of obesity. However, the mechanisms for the development of obesity hypertension are not known. One mechanism proposed is that the hyperinsulinemia present in obese hypertensive patients causes hypertension via sodium retaining and/or sympathetic nervous system stimulatory effects. However, numerous studies in dogs have revealed no evidence for such chronic pressor actions of hyperinsulinemia. This is in close agreement with studies in human insulinoma patients that show marked hyperinsulinemia and normal blood pressure. The appropriateness of the dog as an experimental model is strengthened by reports from our laboratory and others that inducing obesity in dogs reproduces many of the characteristics of obesity in humans, including insulin resistance, hyperinsulinemia, sodium retention, hypertriglyceridemia and hypertension. Recent studies in obese dogs have indicated that significant increases in renal medullary cellularity and intercellular matrix deposition could contribute to the sodium retention and hypertension. Additional evidence suggests that sympathetic nervous system stimulation also may contribute to the elevated blood pressure. However, the mechanisms through which obesity induces these changes and the temporal relationship between these factors and the development of the hypertension remains to be determined.
authors.affiliation: University of Mississippi Medical Center, Jackson 39216-4505, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Brands
authors.forename: J E
authors.initials: JE
authors.lastname: Hall
authors.forename: B N
authors.initials: BN
authors.lastname: Van Vliet
authors.forename: M
authors.initials: M
authors.lastname: Alonso-Galicia
authors.forename: G A
authors.initials: GA
authors.lastname: Herrera
authors.forename: D
authors.initials: D
authors.lastname: Zappe
mesh_terms: D000818:Animals; D004041:Dietary Fats / Q000009:adverse effects; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications*; D006973:Hypertension / Q000209:etiology*; D007328:Insulin / Q000097:blood; D007668:Kidney / Q000378:metabolism*; D009765:Obesity / Q000150:complications*; D013564:Sympathetic Nervous System / Q000502:physiology*
chemical_list: D004041:Dietary Fats; D007328:Insulin